Magnerot

Magnesium Orotate Dihydrate, the active ingredient in Magnerot, is a magnesium supplement presented as an oral supplement for oral use. It helps address magnesium deficiency, muscle cramps and supports cardiovascular function.

GNH USA supplies Magnerot as a licensed, GDP-compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

Magnerot (magnesium orotate dihydrate) is used to replenish magnesium levels and support related physiological pathways.

- Magnesium deficiency: restores normal serum magnesium concentrations. - Muscle cramps: reduces frequency and intensity of involuntary muscle contractions. - Cardiovascular support: contributes to myocardial stability and normal heart rhythm.

Magnerot is generally well tolerated, but adverse reactions can occur.

Common Side Effects: - Diarrhea: loose stools occurring after oral intake. - Nausea: feeling of queasiness or urge to vomit. - Abdominal cramping: mild to moderate stomach discomfort. - Headache: transient head pain.

Serious or Rare Side Effects: - Hypermagnesemia: elevated serum magnesium leading to cardiac arrhythmia. - Low blood pressure: symptomatic hypotension. - Allergic reaction: rash, itching, or swelling. - Respiratory depression: slowed breathing in severe cases.

When using Magnerot, consider the following safety measures.

- Assess renal function: impaired kidneys may reduce magnesium clearance. - Monitor serum magnesium: avoid excessive accumulation. - Adjust dose in elderly: age‑related changes may increase sensitivity. - Avoid use with known hypersensitivity: discontinue if allergic signs appear. - Store at ambient temperature: keep in the original container, protect from moisture and direct sunlight.

Magnerot may interact with other medicines; awareness of the interaction level is important.

Major Interactions (Avoid): - Tetracycline antibiotics: reduced absorption of both agents. - Fluoroquinolone antibiotics: chelation may lower antibiotic effectiveness. - Bisphosphonates: concurrent intake can impair bisphosphonate absorption. - Potassium‑sparing diuretics: risk of additive hypermagnesemia.

Moderate Interactions (Monitor Closely): - ACE inhibitors: may enhance hypotensive effect. - Loop or thiazide diuretics: can alter electrolyte balance. - Proton pump inhibitors: may affect magnesium status over long term. - Oral contraceptives: possible slight reduction in magnesium levels. - NSAIDs: combined use may increase renal load.